4 completed, 1 recruiting. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 4, Recruiting 1 |
Follow Common Variable Immunodeficiency: new trials by email Literature Review of Common Variable Immunodeficiency trials Research Report on Common Variable Immunodeficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease Hizentra - Common Variable Immunodeficiency | Phase 4 | Recruiting | University of Alabama at Birmingham | 22 | 2024-01-15 | 2026-05-04 |
| A Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions C1-esterase inhibitor [recombinant] (C1-INH-R) - CVI - Common Variable Immunodeficiency | Phase 4 | Completed | IMMUNOe Research Centers | 20 | 2018-06-13 | 2021-02-15 |
| The Rifaximin Study in CVID Rifaximin - Common Variable Immunodeficiency (CVID) | Phase 4 | Completed | Oslo University Hospital | 40 | 2013-10-01 | 2015-04-24 |
| A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency Gammaplex - Primary Immune Deficiency Disorders, Common Variable Immunodeficiency | Phase 4 | Completed | Bio Products Laboratory | 25 | 2011-03-01 | 2014-12-23 |
| Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency Vivaglobin - Common Variable Immunodeficiency, Agammaglobulinemia | Phase 4 | Completed | CSL Behring | 18 | 2007-03-01 | 2013-06-20 |
Bruton type agammaglobulinemia (2) · Primary Immunodeficiency Diseases (2) · Agammaglobulinemia (1) · Angioedemas, Hereditary (1) · Bacterial Infections (1) · Drug-Related Side Effects and Adverse Reactions (1) · Hyper-IgM Immunodeficiency Syndrome (1) · Wiskott-Aldrich Syndrome (1)
Immune System Diseases (5) · Immunologic Deficiency Syndromes (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Blood Protein Disorders (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Angioedema (1) · Bacterial Infections and Mycoses (1) · Blood Coagulation Disorders (1) · Blood Coagulation Disorders, Inherited (1) · Cardiovascular Diseases (1) · Chemically-Induced Disorders (1) · Cytopenia (1) · Dysgammaglobulinemia (1)
Complement C1 Inhibitor Protein (1) · Hizentra (1) · Rifaximin (1) · Vivaglobin (1) · gamma-Globulins (1)
Bio Products Laboratory (1) · CSL Behring (1) · IMMUNOe Research Centers (1) · Oslo University Hospital (1) · University of Alabama at Birmingham (1)
United States (3) · Canada (1) · Chile (1) · Germany (1) · Israel (1) · Italy (1) · Norway (1) · Spain (1)
Borre Fevang, MD, Phd (1) · Harry Schroeder, MD/PhD (1) · Isaac Melamed, MD (1) · Michael Borte, MD (1) · Tim J. Aldwinckle, MD (1)